erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Vagus Nerve Injuries D061223 1 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Bach MC The chemotherapy of infections due to nocardia. 1975 Int J Clin Pharmacol Biopharm pmid:1099020
Komine M and Tamaki K An open trial of oral macrolide treatment for psoriasis vulgaris. 2000 J. Dermatol. pmid:10989574
Shivakumar AG et al. Studies on the synthesis of plasmid-coded proteins and their control in Bacillus subtilis minicells. 1979 Plasmid pmid:109873
Horodniceanu T et al. Conjugative R plasmids in Streptococcus agalactiae (group B). 1979 Plasmid pmid:109871
Phan LT et al. Synthesis of 2-fluoro-6-O-propargyl-11,12-carbamate ketolides. A novel class of antibiotics. 2000 Org. Lett. pmid:10986080
Khan AA et al. Ketolide ABT-773 is active against Toxoplasma gondii. 2000 J. Antimicrob. Chemother. pmid:10980181
Juliani MH et al. Induction of rho-minus mutants in Saccharomyces cerevisiae by guanidine hydrochloride. I. Genetic analysis. 1975 Mutat. Res. pmid:1097911
Khan SA et al. Characterization of erythromycin-resistant methylase genes from multiple antibiotic resistant Staphylococcus spp isolated from milk samples of lactating cows. 2000 Am. J. Vet. Res. pmid:10976747
Lakritz J et al. Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. 2000 Am. J. Vet. Res. pmid:10976728
Volchegursky Y et al. Biosynthesis of the anti-parasitic agent megalomicin: transformation of erythromycin to megalomicin in Saccharopolyspora erythraea. 2000 Mol. Microbiol. pmid:10972798
Barbacid M et al. The mode of action of griseoviridin at the ribosome level. 1975 Biochim. Biophys. Acta pmid:1096949
Camardella L et al. Nuclear and cytoplasmic glutamate dehydrogenases (NADP-dependent) in Saccharomyces cerevisiae. 1975 Biochem. Biophys. Res. Commun. pmid:1096883
Palmer NA et al. A study of prophylactic antibiotic prescribing in National Health Service general dental practice in England. 2000 Br Dent J pmid:10967824
O'Grady FW et al. Sensible prescribing. III. Acute otitis media and sore throat. 1975 Practitioner pmid:1096124
Heude M and Chanet R Protein synthesis and the recovery of both survival and cytoplasmic "petite" mutation in ultraviolet-treated yeast cells. II. Mitochondrial protein synthesis. 1975 Mutat. Res. pmid:1095920
Hatipoglu ON and Tasan Y A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia. 2000 Yonsei Med. J. pmid:10957888
Williams DA Stevens-Johnson syndrome after erythromycin therapy while deployed at sea. 2000 Mil Med pmid:10957862
Mobley DF Semen cultures in the diagnosis of bacterial prostatitis. 1975 J. Urol. pmid:1095783
Xiang H et al. An A245T mutation conveys on cytochrome P450eryF the ability to oxidize alternative substrates. 2000 J. Biol. Chem. pmid:10956654
Durieu-Trautmann O and Tavlitzki J Reversible and permanent effects of the carbon sources and various antibiotics on the morphology and metabolic properties of Ustilago cynodontis cells. 1975 J. Cell Biol. pmid:1095594
Bebear CM et al. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. 2000 Antimicrob. Agents Chemother. pmid:10952617
Goldstein EJ et al. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections. 2000 Antimicrob. Agents Chemother. pmid:10952607
Pendland SL et al. In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori. 2000 Antimicrob. Agents Chemother. pmid:10952605
Masuda N et al. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. 2000 Antimicrob. Agents Chemother. pmid:10952562
Lakritz J et al. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. 2000 Am. J. Vet. Res. pmid:10951982
Lozniewski A et al. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae. 2000 Pathol. Biol. pmid:10949841
Johnston WS Eradication of STR agalactiae from infected herds using erythromycin. 1975 Vet. Rec. pmid:1094673
Wardrop J et al. Determination of erythromycin and related substances in enteric-coated tablet formulations by reversed-phase liquid chromatography. 2000 J Pharm Sci pmid:10944374
De Soyza A et al. An unusual case of pulmonary abscess. 2000 J. Infect. pmid:10942653
Burkhart CN et al. Synergistic activity of benzoyl peroxide and erythromycin. 2000 Sep-Oct Skin Pharmacol. Appl. Skin Physiol. pmid:10940820
Slain D et al. Variability in activity of hepatic CYP3A4 in patients infected with HIV. 2000 Pharmacotherapy pmid:10939550
Leaf T et al. Precursor-directed biosynthesis of 6-deoxyerythronolide B analogs in Streptomyces coelicolor: understanding precursor effects. 2000 Jul-Aug Biotechnol. Prog. pmid:10933827
Wasilewski MM et al. Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections. 2000 J. Antimicrob. Chemother. pmid:10933649
Schultz MJ et al. Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae. 2000 J. Antimicrob. Chemother. pmid:10933646
Eady EA et al. Antibiotic resistance patterns of aerobic coryneforms and furazolidone-resistant Gram-positive cocci from the skin surface of the human axilla and fourth toe cleft. 2000 J. Antimicrob. Chemother. pmid:10933642
Dreassi E et al. High-performance liquid chromatographic assay of erythromycin from biological matrix using electrochemical or ultraviolet detection. 2000 Analyst pmid:10932853
Hashemi K et al. Comparison of antibiotic drops placed in the conjunctival cul-de-sac to antibiotic ointment applied to the lid margin in reduction of bacterial colonization on the lid margin. 2000 Cornea pmid:10928757
Hammerschlag MR Treatment of Chlamydia pneumoniae. 2000 Int. J. Antimicrob. Agents pmid:10926449
Lin HC et al. Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils. 2000 Respir Med pmid:10926336
Zaloga GP and Marik P Promotility agents in the intensive care unit. 2000 Crit. Care Med. pmid:10921616
Chapman MJ et al. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. 2000 Crit. Care Med. pmid:10921561
Joshi A et al. Palmar erythema nodosum. 2000 J. Dermatol. pmid:10920594
Yost NP et al. An appraisal of treatment guidelines for antepartum community-acquired pneumonia. 2000 Am. J. Obstet. Gynecol. pmid:10920320
Zhang Y et al. Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae. 2000 RNA pmid:10917591
Rudolph KM et al. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998. 2000 J. Infect. Dis. pmid:10915080
Kobayashi Y et al. Development of a competitive polymerase chain reaction assay for the ruminal bacterium Butyrivibrio fibrisolvens OB156 and its use for tracking an OB156-derived recombinant. 2000 FEMS Microbiol. Lett. pmid:10913703
Lin FY et al. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. 2000 Clin. Infect. Dis. pmid:10913400
Lacey RW Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance. 1975 Bacteriol Rev pmid:1091256
Zueva VS et al. [Dynamics of the antibiotic sensitivity of the staphylococci in suppurative, inflammatory foci in patients during the period of the hospital stay]. 1975 Antibiotiki pmid:1091206
Stratton-Phelps M et al. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). 2000 J. Am. Vet. Med. Assoc. pmid:10909450